Crystal Structures of T. b. rhodesiense Adenosine Kinase and Its Inhibitor
Author Information
Author(s): Sabine Kuettel, Jason Greenwald, Dirk Kostrewa, Shaheen Ahmed, Leonardo Scapozza, Remo Perozzo
Primary Institution: Pharmaceutical Biochemistry Group, School of Pharmaceutical Sciences, University of Geneva, University of Lausanne, Lausanne, Switzerland
Hypothesis
The study investigates the structural basis of adenosine kinase from Trypanosoma brucei rhodesiense and its interaction with inhibitors and activators.
Conclusion
The study provides insights into the binding mechanisms of adenosine kinase and its activator, which may lead to new treatments for Human African Trypanosomiasis.
Supporting Evidence
- The study presents the first crystal structures of TbrAK in complex with the inhibitor AP5A and the activator compound 1.
- The findings suggest that compound 1 can hyperactivate TbrAK, which may lead to new therapeutic strategies.
- The structural analysis reveals important details about substrate and activator binding mechanisms.
Takeaway
Scientists looked at how a specific enzyme in a parasite works and how a new drug can help it work better, which could help treat a serious disease.
Methodology
The study used crystallography to determine the structures of the adenosine kinase in complex with an inhibitor and an activator.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website